FCA Corp TX Buys Shares of 12,000 Roche Holding AG $RHHBY

Key Points

• FCA Corp TX invested approximately $494,000 in Roche Holding AG by purchasing 12,000 shares in the first quarter of 2023.
• Other notable investments include GAMMA Investing LLC, which increased its holdings by 6,463.8% to 528,778 shares, valued at approximately $21.76 million.
• Roche's stock has seen a 1.2% increase, with current trading prices reflecting a 52-week range from $34.10 to $44.31.

FCA Corp TX bought a new position in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 12,000 shares of the company's stock, valued at approximately $494,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Fulton Bank N.A. boosted its position in shares of Roche by 2.6% during the first quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after buying an additional 314 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of Roche by 2.0% during the first quarter. PNC Financial Services Group Inc. now owns 16,234 shares of the company's stock worth $668,000 after buying an additional 323 shares during the period. Confluence Investment Management LLC boosted its position in shares of Roche by 3.6% during the first quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after buying an additional 510 shares during the period. Accent Capital Management LLC acquired a new position in shares of Roche during the first quarter worth about $35,000. Finally, North Star Asset Management Inc. boosted its position in shares of Roche by 7.8% during the first quarter. North Star Asset Management Inc. now owns 17,305 shares of the company's stock worth $712,000 after buying an additional 1,255 shares during the period.

Analysts Set New Price Targets

Several research analysts recently commented on RHHBY shares. HSBC cut Roche from a "buy" rating to a "hold" rating in a research report on Monday, April 28th. Hsbc Global Res cut Roche from a "strong-buy" rating to a "hold" rating in a research report on Monday, April 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Roche presently has an average rating of "Moderate Buy".

Roche Trading Up 0.1%

Roche stock traded up $0.03 during mid-day trading on Monday, reaching $39.61. 1,204,811 shares of the company were exchanged, compared to its average volume of 2,324,174. The company has a fifty day simple moving average of $40.08 and a 200-day simple moving average of $40.26. Roche Holding AG has a 12 month low of $34.10 and a 12 month high of $44.31. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.48 and a quick ratio of 1.20.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.